Group B Sox genes, Sox1, -2 and -3 are known to activate crystallin genes and to be involved in differentiation of lens and neural tissues. Screening of chicken genomic sequences for more Group B Sox genes identi®ed two additional genes, Sox14 and Sox21. Proteins encoded by Sox14 and Sox21 genes are similar to each other but distinct from those coded by Sox1-3 (subgroup B1) except for the HMG domain and Group B homology immediately C-proximal of the HMG domain. C-terminal domains of SOX21 and SOX14 proteins function as strong and weak repression domains, respectively, when linked to the GAL4 DNA binding domain. These SOX proteins strongly (SOX21) or moderately (SOX14) inhibited activation of d1-crystallin DC5 enhancer by SOX1 or SOX2, establishing that Sox14 and Sox21 are repressing subgroup (B2) of Group B Sox genes. This provides the ®rst evidence for the occurrence of repressor SOX proteins. Activating (B1) and repressing (B2) subgroups of Group B Sox genes display interesting overlaps of expression domains in developing tissues (e.g. optic tectum, spinal cord, inner ear, alimentary tract, branchial arches). Within each subgroup, most expression domains of Sox1 and -3 are included in those of Sox2 (e.g. CNS, PNS, inner ear), while co-expression of Sox14 and Sox21 occurs in highly restricted sites of the CNS, with the likely temporal order of Sox21 preceding Sox14 (e.g. interneurons of the spinal cord). These expression patterns suggest that target genes of Group B SOX proteins are ®nely regulated by the counterbalance of activating and repressing SOX proteins. q
Introduction
A growing number of transcription factors governing embryogenesis have been identi®ed, and these form distinct families characterized by the nature of their DNA binding domains. Owing to the shared characteristics of the DNA binding domains, the transcription factors of a family bind to a common set of DNA sequences (e.g. Hayashi and Scott, 1990 , for HOX family proteins). It is generally observed that multiple transcription factors of the same family are expressed with a signi®cant overlap of expression domains, raising the possibility that these factors interact on the same regulatory sites of a gene and in¯uence expression of the target gene in qualitatively and quantitatively different ways. These interactions are of great importance in the control of organogenesis where highly tuned spatiotemporal order of regulation of cell growth, differentiation and cell-cell interactions are required.
SOX family proteins have 79 amino acid DNA binding domains (HMG domains) coded by SRY-related HMG box DNA sequences and consisting of more than 20 members in a vertebrate species. These are the best examples of transcription factors having similar DNA binding speci®cities yet with divergent functions. Their HMG domains show amino acid identity scores of over 50% compared to that of Sry, the prototype SOX factor involved in sex determination (Gubbay et al., 1990; Wright et al., 1993; Pevny and Lovell-Badge, 1997) . SOX family proteins are classi®ed into seven groups according to their HMG domain sequences initially registered based on domain cloning by PCR (Wright et al., 1993; Pevny and Lovell-Badge, 1997) . Within one group of SOX proteins the amino acid sequences of the HMG domains are more than 90% identical, but between the groups the identity is signi®cantly lower. Subsequent cloning of wider regions of coding sequences generally veri®ed the HMG domain-based classi®cation of the groups: within a group amino acid sequences are fairly conserved throughout the polypeptide length, implying related regulatory functions, but between the groups no signi®cant similarities exist except for the HMG domain. All SOX proteins thus far characterized in detail bear activation domains and are involved in activation of the genes (Pevny and Lovell-Badge, 1997, for review) .
SOX2, belonging to Group B, has been fairly well characterized regarding its regulatory functions and its expression in embryogenesis. It was identi®ed as an essential factor to activate crystallin genes in the lens cells (Kamachi et al., 1995; , and was subsequently found to regulate FGF4 gene in teratocarcinoma cells (Yuan et al., 1995) . Analyses of early embryos have revealed that Sox2 is widely expressed in the nervous system in the chicken and Xenopus (Uwanogho et al., 1995; Streit et al., 1997; Rex et al., 1997a; Mizuseki et al., 1998) , and Sox2 expression is found to be correlated with the neural competence of the ectoderm (Streit et al., 1997; Mizuseki et al., 1998) .
Analysis of mouse Sox genes showed Sox1 and Sox3 genes to be highly related to Sox2 (Gubbay et al., 1990; Collignon et al., 1996) . In the chicken and Xenopus, it has been shown that Sox3 is expressed from early in embryogenesis and widely in the central nervous system (Uwanogho et al., 1995; Rex et al., 1997a; Penzel et al., 1997) . Sox1 is implicated in neurogenesis during differentiation of P19 teratocarcinoma cells and in mouse embryo CNS (Pevny et al., 1998) . In addition, these related Sox genes are expressed in the lens (Kamachi et al., 1995; , and Sox1-de®cient mice produced by gene targeting have demonstrated that Sox1 is essential for lens development (Nishiguchi et al., 1998) .
This work was initiated to explore the possible existence of more Group B members of Sox genes. Screening and cloning of genomic sequences of the chicken embryos identi®ed two Sox genes having the HMG-box with high similarity to Sox1-3. Comparison of the sequences indicated that one of them corresponds to Sox14, previously reported only for the HMG box sequence (Wright et al., 1993) , and the other to chicken Sox21 recently isolated by Rex et al. (1997b) . We show here that SOX14 and SOX21 are very similar throughout the length of the amino acid sequence, but their resemblance to SOX1-3 exists only in the HMG domain and its immediate C-proximal Group B homology, indicating that Sox14 and Sox21 genes comprise subgroup B2 distinct from Sox1-3 comprising subgroup B1. More importantly, SOX14 and SOX21 have a repression domain at their C-termini, and they in fact repress the d1-crystallin DC5 enhancer activated by SOX1/2.
Examination of expression of all these members of Group B Sox genes during embryogenesis demonstrates interesting overlaps of their expression domains, implicating their functional interactions during organogenesis. Particularly in such tissue domains that coexpress Sox genes of subgroups B1 and B2, the target genes may be regulated by the counterbalance of activating and repressing SOX proteins.
Results

Cloning of the Sox14 and Sox21 genes of the chicken
The full coding sequences of chicken Sox1 (Kamachi et al., 1998) , Sox2 (Kamachi et al., 1995; Uwanogho et al., 1995) and Sox3 (Uwanogho et al., 1995; Kamachi et al., 1998) genes of the chicken, all of which belong to Sox Group B have been previously published. In order to search for more Group B genes, we screened genomic libraries of the chicken using the HMG box-containing fragment of the Sox2 cDNA. This screening identi®ed two independent clones for each of Sox1, Sox2 and Sox3. Analysis of these clones in comparison with the cDNA sequences con®rmed that these three Sox genes are intronless within open reading frames, as reported for mouse/human genes (Pevny and Lovell-Badge, 1997, for review) .
In addition, the screening identi®ed two clones, G7 and G16, of novel Sox genes with the HMG box sequences assignable to Group B. Roughly 3 kb sequences around the HMG domains were determined (data not shown), which indicated that these genes potentially code for similar proteins. The deduced HMG domain amino acid sequence coded by G16 was identical to that of mouse SOX14 where only the HMG box sequence had been available (Wright et al., 1993) . We thus assigned G16 to the gene for Sox14 of the chicken. G7-encoded protein was novel, but was subsequently found almost identical to the recently reported chicken SOX21 cDNA clone (Rex et al., 1997b) . Therefore, G7 was assigned to the gene for Sox21. Comparison of the genomic (G7) and the cDNA sequences indicated that Sox21 is also an intronless gene.
The SOX14 protein predicted from the genomic sequence shows remarkable similarities to the SOX21 protein (Fig.  1A ). It has a 5 amino acid N-terminal sequence with 4/5 matches which continues to the HMG domains (75/79 matches). The C-terminal domains of these proteins are also highly similar throughout their length. From these, we presume that Sox14 coding sequence is not interrupted by an intron sequence and that the translation of the G16 open reading frame is the protein sequence of the chicken SOX14. Comparison with chicken Sox14 cDNA sequence (M. Hargrave, T. Yamada and P. Koopman, personal communication) con®rms this notion.
Two subgroups of Group B Sox genes coding for activators and repressors
Comparison of the amino acid sequences of SOX1, -2, -3, -14 and -21 (Fig. 1B,C) indicated that the former three and the latter two clearly constitute two distinct subgroups of Group B Sox genes, which we call B1 and B2, respectively. Between subgroups B1 and B2, similarity was limited to the HMG domain and its immediate C-proximal region, Group B homology (Fig. 1B,C ), but within a subgroup similarities extend to the remaining portions of the proteins (Fig. 1C) .
We previously reported that all SOX1, -2 and -3 of subgroup B1 bind and activate the DC5 minimal enhancer of the chicken d1-crystallin gene (Kamachi et al., 1995, 1998). We examined whether SOX14 and SOX21 are able to bind and activate the DC5 enhancer.
Approximately 200 amino acid long N-terminal portions of the SOX proteins containing the HMG domain were synthesized in vitro, and subjected to the electrophoretic mobility shift assay using a subfragment of DC5 as probe ( Fig. 2A) . As expected from the similarity of the HMG domain, all these HMG-containing proteins bound to the probe with similar af®nities.
The potential of SOX14 and SOX21 proteins to activate the DC5 minimal enhancer was compared with that of SOX1. As shown in Fig. 2B , transfection of Sox14 and Sox21 coding sequences in expression vectors failed to activate DC5-bearing luciferase gene, in contrast to the case of Sox1. Rather, it was noted that SOX21 decreased the luciferase expression, raising the possibility that they repressed the enhancer.
To explore the nature of SOX14 and SOX21 as transcriptional regulators, C-terminal portions of these proteins were ligated to the GAL4 DNA binding domain, and their effect on GAL4 binding site-bearing luciferase reporter gene was examined in transfected cells. In analogous assays previously done for other SOX proteins, C-terminal portions showed a transactivation potential: SOX1-3 (Kamachi et al., 1995; 1999) ; SOX4 (van de Wetering et al., 1993) ; SOX9 (Su Èdbeck et al., 1996; Ng et al., 1997; Kamachi et al., 1999) ; SOX10 (Pusch et al., 1998) ; SOX11 (Kuhlbrodt et al., 1998b) ; SOX18 (Hosking et al., 1995) ; SOX24 (Kanda et al., 1998) .
Both in lens cells (Fig. 2C ) and in ®broblast (data not shown), the C-terminal portion of SOX1 activated luciferase expression as reported by Kamachi et al. (1999) , but by contrast the C-terminal portion of SOX21 repressed the luciferase expression in a manner dependent on the amount of the transfected effector plasmid. SOX14 C-terminal portion also showed the activity of transrepression, but the effect was less pronounced compared to SOX21.
To characterize more directly the nature of SOX21 and SOX14 proteins, we examined their effect on a reporter gene carrying octameric DC5 enhancer sequence activated by exogenous SOX1 in lens cells (Fig. 2D) . The effect of activator SOX2 in the assay was also examined for comparison. Addition of SOX2 expression plasmid to SOX1 plasmid did not affect much the luciferase expression level, since activation of DC5 enhancer by SOX proteins was already saturated (Kamachi et al., 1995 (Kamachi et al., , 1998 . By contrast, SOX21 sharply, and SOX14 modestly, repressed the activation of DC5 by SOX1, in an amount-dependent fashion. When the C-terminal portion of SOX21 was deleted, repression by SOX21 was strongly attenuated (Fig. 2D, 4th panel) , demonstrating that the transrepression activity associated with the C-terminal portion of SOX21 is actually involved in the repression by the intact SOX21 protein.
Taken together, SOX21 and SOX14 of subgroup B2 are strong and modest repressors, respectively, which may interfere with activation by SOX proteins of subgroup B1, if expressed in the same cells.
Expression of Group B Sox genes in early embryos.
Given that subgroup B1 and subgroup B2 of SOX proteins have opposite activities as transcriptional regulators, and that the potencies of transactivation/transrepression are variable within a subgroup, it is important to know how these related SOX proteins are expressed individually or in combination in developing tissues. Histological analysis to be described below illustrates that Group B Sox genes are expressed in various combinations, which may be categorized in a few basic patterns.
Previous reports described expression of Sox2, -3 and -21 in early embryogenesis of the chicken in certain detail (Uwanogho et al., 1995; Rex et al., 1997a,b; Streit et al., 1997) , but expression of Sox1 and Sox14 is described here for the ®rst time. In addition, we report expression of all Group B Sox genes in later organogenic stages.
Expression pro®les of Sox1, -14 and -21 in chicken embryos of relatively early stages (stages 4 to 14) (Hamburger and Hamilton, 1951) were examined in whole mount specimens. Representative specimens of stage 11 are shown in Fig. 3 . The CNS is the major site of expression of Sox1 and Sox21, as it is for Sox2 and Sox3 (Streit et al., 1997; Rex et al., 1997a) . Expression of Sox21 in the CNS primordium starts at stage 4 (Rex et al., 1997b ; data not shown), while expression of Sox1 is initiated only at stage 7 when neural fold closure begins in the head process (data not shown). Expression of Sox14 in the nervous system becomes detectable only after stage 21 (3 days). amino acid portions of the SOX proteins were synthesized in vitro using the TNT system as fusion proteins with S-Tag and their binding to the d1-crystallin minimal enhancer sequence was compared by gel mobility shift assay. The minor bands which migrate faster than the major bands probably represent HMG domain-containing, truncated proteins created during in vitro reaction. Under the condition employed in this assay, certain differences in the af®nity of the HMG domains to the DNA sequence are detectable (Kamachi et al., 1999) . (B) Effect of exogenous SOX proteins on DC5 enhancer in lens cells. Luciferase reporter gene having octamerized DC5 minimal enhancer and d-crystallin minimal promoter (d-Cry pro) were co-transfected in lens cells with the effector plasmids with Sox cDNAs placed downstream of the cytomegalovirus immediate early promoter (CMV). The expression level of the reporter without exogenous Sox was taken as 1. (C) Regulatory activities of the C-terminal domains of the SOX proteins. The luciferase reporter plasmid contained tetramerized GAL4 binding sites upstream of Herpes simplex virus thymidine kinase (tk) promoter. C-terminal domains of SOX proteins (x) were fused in frame to GAL4DBD. Various amounts of effector plasmids expressing GAL4-SOX proteins were transfected into lens cells with the luciferase reporter plasmid and compared with GAL4DBD. (D) Effect of SOX14, SOX21 and its C-terminal deletion form, SOX21(1-125)DC, on DC5 enhancer activated by SOX1. DC5 enhancer was activated using 1 ng of SOX1 plasmid and effect of varying amounts of co-transfected SOX2, -14 and -21 plasmids were examined. The portion of SOX21 corresponding to SOX21(1-125)DC is schematically shown at the top.
Expression in the spinal cord
The radial pattern of Sox gene expression in the CNS is typically represented by the spinal cord of stage 21 (3 day) embryos (Fig. 4) . Expression of Sox1 occurs in the ventricular zone similar to Sox2/3 (Uwanogho et al., 1995; Rex et al., 1997a; Streit et al., 1997) , but is con®ned to the lateral walls, and excluded from the¯oor and roof plates (Fig. 4A ).
In earlier stages, Sox1 is expressed in the¯oor portion of the neural tube in addition to the lateral portions, but their expression in the¯oor is lost around stage 13, probably re¯ecting the¯oor plate differentiation. This is fairly similar to Sox3 expression (Uwanogho et al., 1995) . Sox21 is expressed in the ventricular zone and the¯oor plate ( Fig.  4A) , showing a resemblance to Sox2 (Uwanogho et al., 1995; Rex et al., 1997a; Streit et al., 1997; Kamachi et al., 1998) . In addition, dorso-ventral striation of Sox21 expression in the spinal cord is observed (Fig. 4A , e.g. stage 15) which also occurs in earlier embryos (Rex et al., 1997b) . Sox14 is not expressed in the ventricular zone.
Another component of Sox21 expression related to that of Sox14 is apparent at the 3 day stage and becomes clearer in later stages (Fig. 4A ). In stage 21 embryos, some of the cells in the ventro-medial region of the intermediate zone express Sox21 (Fig. 4A, arrowhead) , and this ex-ventricular expression includes a small population of cells expressing Sox14 (Fig. 4A, arrowhead) . In 4 day embryos, the overlap of Sox14 and Sox21 expression outside of the ventricular zone is clearer, and in 6 day embryos expression of Sox14 dominates over that of Sox21 (Fig. 4A ). These Sox14-positive cells located dorsal to the motor columns are likely to be interneurons (Hargrave et al., personal communication) . Therefore, there seems to be a transition of expression from Sox21 to Sox14 during maturation of the interneuron population. It is noted that Sox1 is also expressed very transiently (around day 4) and in a small subpopulation of Sox14/ Sox21-expressing cells in the ex-ventricular area (Fig. 4A ).
Expression in the developing brain
To map the expression domains of Group B Sox genes in the brain, 5 day embryo brain was cut along the midline and hybridized in whole mount. Representative specimens and the schemes of Sox expression are shown in Figs. 5A and 5B, respectively.
Sox2 is expressed most widely in the brain, and the highest level of expression occurs in the telencephalon (te) and mesencephalon (me). Expression in the diencephalon (di) is rather complex. It has been proposed that the diencephalon is composed of four major compartments, D1 to D4, from rostral to caudal (Figdor and Stern, 1993) . In the D1 compartment, expression of Sox2 is strong in the ventral thalamus (vt), the hypothalamus (ht) and the most rostral part of the preoptic area (po), but is very weak in the mammillary area (ma). In the dorsal thalamus (D2), Sox2 is prominently expressed in the rostral half. Expression in D3 is con®ned to the rostral arc, while expression in D4 is very low. Sox1 and Sox3 are expressed mainly in the subsets of Sox2-expressing domains rostral to the mesencephalon; their expression in the mesencephalon is moderate. The boundaries of the expression domains of Sox1 and Sox3 in the telencephalon and the diencephalon probably demarcate the subdivisions in brain organization.
Sox21 is broadly expressed in the brain, extensively overlapping with Sox2 expression in the telencephalon (te), preoptic area (po), ventral thalamus (vt) and mesencephalon (me). A signi®cant difference, however, is that Sox21 expression is absent in the major part of the dorsal thalamus (D2), producing a prominent gap of Sox21 expression in the middle of the brain. This gap becomes apparent at stage 9 (data not shown) and is clearly observed in the specimens of later stages (Figs. 3 and 5A and data not shown). Thus, the dorsal thalamus is the domain where a repressing activity of SOX21 is largely absent.
Sox14 displays a unique expression pattern. It is strongly expressed in the most rostral (adjacent to the telencephalon) part of the preoptic area (po), the rostral half of the basal zone of the hypothalamus (ht), a narrow band of the dorsal thalamus (D2) along the zona limitans intrathalamica (zl), caudal half of the pretectum (D4) and the mesencephalon (me).
In the juvenile cerebellum at stage 27 (5 day), Sox1, -3 and -21 are clearly expressed. Expression of Sox2 is low at this stage, although it becomes signi®cant in a later period (Fig. 6, see below) . Expression of Sox14 in the cerebellum remains absent (Figs. 5A and 6).
Expression of Sox1 and Sox3 generally occurs in the ventricular zone, while Sox2 and Sox21 are also expressed outside this zone in some of the domains (Fig. 4A) . Sox14 expression occurs outside the ventricular zone, as observed in the spinal cord. An example of ex-ventricular expression of Sox2, 21 and 14 is shown in Fig. 4B . These sections show stage 29 (6 day) embryo brain from the epiphysis (ep) through the dorsal portion of the zona limitans intrathalamica (zl) to the most anterior part of the preoptic area (po). Sox2 is expressed throughout the ventricular zone, and there is also a cell population strongly expressing Sox2 which occupies the internal cellular area of the dorsal thalamus (Fig. 4B, id) and which is located dorsal to the zona limitans intrathalamica (zl). Sox21 expression in the ventricular zone is absent in the more dorsal portion. In the ventral border of the internal cellular area of the dorsal thalamus (id) there is a population of cells which express both Sox21 and Sox14 and are probably migrating vertically from the Sox21-positive ventricular zone toward the pial side. Sox14 expression is stronger away from the ventricle, suggesting that a gradual transition of expression may occur from Sox21 to Sox14 in the cell population. These cells seem to spread along the outer pial surface to form the external cellular area of the dorsal thalamus (ed) and express Sox14 strongly and Sox21 weakly. Thus, as already mentioned for an interneuron population in the spinal cord, there are cell populations of the CNS which ®rst express repressing Sox21 in addition to activating Sox2 in the ventricular zone, then Sox21 and Sox14 together in the intermediate zone and eventually Sox14 dominating over Sox21 in the external area. It is also interesting to note that the more dorsally located portion of the internal cellular area of dorsal thalamus (id) expresses activating Sox2 rather than repressing Sox21/ 14. This implies that two distinct cell populations are produced in the internal cellular area by the opposing activities of Group B SOX proteins.
Expression of Group B Sox genes in the later development of the CNS was compared by Northern blot analysis of poly(A)1 RNAs derived from various portions of the brain of 13 day embryos (Fig. 6 ). Lens RNA from 14 day embryos was also included in the analysis. Sox genes of subgroup B1 are expressed in all portions of the brain of this stage and in the lens. Expression of Sox21 is also detected in all portions of the brain, but its distribution appears different from subgroup B1, e.g. relatively high in the mesencephalon and relatively low in the rhombencephalon. Sox14 is unique in its expression, absent in the telencephalon and cerebellum, and very high in the mesencephalon. Expression of the subgroup B2 genes is not detected in the lens of 14 day embryos.
Expression in the optic tectum
In the optic tectum also, Sox2, -14 and -21 are expressed outside the ventricular zone. The ventricular zone cells express Sox1, -2, -3 and -21 in all stages we examined (data not shown). In the 6 day tectum (Fig. 7A) , Sox21 is expressed in the ventricular zone and two additional cell populations, one located in an intermediate zone (I) likely representing the nascent post-mitotic neural populations, and the other located in the layers close to the external surface (Ex1/2), being stronger in the more internal compartment of the latter (Ex1). Sox14 is expressed in the same intermediate zone (I) and more strongly in the external zone (Ex1/2). The sequence of expression of the repressing Sox genes, starting from Sox21 and ending in Sox14, seems to hold there. Sox2 is expressed in the most external zone (Ex2) in addition to the ventricular zone.
In fact in the tectum of 12 day embryo (Fig. 7B) , there are several layers recognized by differential expression of Group B Sox genes, which generally match those de®ned based on morphological features by La Veil and Cowan (1971) . Close to the external surface, there is layer [2/14] expressing Sox2 and Sox14 together, corresponding to layer (x) of La Veil and Cowan (1971) , then layer [14] expressing Sox14 alone and corresponding to layers (ix) and (viii), followed by a layer lacking expression of any Group B Sox genes. Further inward, there is a broad layer expressing Sox2, -14 and -21 together (2/14/21) corresponding to layer (vi), stronger with Sox2 on the more external side of this zone and stronger with Sox21 on the more internal side of the zone. The layer (2/14/21) expressing the three Sox genes probably corresponds to the external zones of 6 day embryo tectum (Ex1 and Ex2), considering the histogenesis of the CNS placing an earlier established layer in a deeper position (Jacobson, 1991) .
Expression in the rhombencephalon
The Group B Sox genes exhibit variations of expression level among the rhombomeres in a way unique to each Sox gene. These variations begin to appear around stage 9 and this initial pattern is maintained up to stage 14. Representative specimens of stage 11 are shown in Fig. 3 and expression data of this stage summarized in Table 1A . At stage 11, expression of Sox1 is characterized by the alternating expression levels in the array of the rhombomeres, high in the even-numbered rhombomeres (r2, r4 and r6) and low in the odd-numbered (r1, r3 and r5). Sox2 expression in the rhombomeres rather resembles that of Sox1, except that it is also strong in r1. Expression of Sox3 is almost complementary to Sox1, and strong in r1, r3 and r5. Expression of Sox21 is weak in r3, implying a regulation shared by Sox1 and Sox2 in this particular rhombomere. Sox14 is not expressed during this period.
The pattern of Sox expression in the rhombomeres changes dynamically with development. Data of stage 21 (3 day) embryos are summarized in Table 1B . Low expression of Sox1 and Sox2 in r5 and low expression of Sox3 in r4 continue from earlier stages, but otherwise expression of Group B Sox genes in the rhombomeres is considerably different from that of earlier stages (Table 1A) .
Later, dorso-ventral striations develop which are conspicuous in stage 27 (5 day) embryos (Fig. 5A inset, 5B) , producing checkerboard-like compartments divided by dorsoventral and rostro-caudal boundaries. The Group B Sox genes are expressed in individually unique sets of these checkerboard-assorted compartments.
Expression in the peripheral nervous system
Sox2 and Sox3 are expressed in the developing peripheral nervous system, but other Group B Sox genes are not. Sox2 is expressed throughout the peripheral nervous system. In the trunk of stage 21 (3 day) embryos, spinal ganglia, sympathetic ganglia, putative Schwann cells and putative parasympathetic nerves express Sox2 (Fig. 8Db , and data not shown). The cells which probably form the adrenomedulla also express Sox2 (data not shown). All cephalic ganglia derived from the neural crest and from the cephalic placode express Sox2. An example of a placodal ganglion, the acoustic ganglion, is shown in Fig. 8C . Therefore, Sox2 marks neural derivatives of the neural crest and cephalic placode, but is not appreciably expressed in the migrating neural crest cells. In contrast, Sox3 is expressed exclusively in the autonomic part of the peripheral nervous system. Sox3 expression is observed in the sympathetic ganglia and parasympathetic nerves in the trunk region and also in the adrenomedulla ( Fig. 8Dc and data not shown).
Expression in the branchial arches and the alimentary tract
At stage 11, the ®rst and second branchial arches express Sox2, -3 and -21 (Fig. 3) . Expression initiates from the most rostral arch and extends to more caudal arches later. As the arches develop, Sox2 and Sox21 continue to be expressed in the endodermal compartment, and this endodermal expression extends to the esophagus and proximal part of the bronchi (Fig. 8Ab,e) , while Sox3 is mainly expressed in the caudal sides of the clefts involving both ectoderm and endoderm (Fig. 8Ac) . Sox14 is expressed only in the ectodermal surface of the mandibular arch (Fig. 8Ad) . Sox1 is not expressed in the branchial arches. Expression of Sox2 and Sox21 in the alimentary tract continues through esophagus and proventriculus, and terminates at the end of the gizzard (Fig. 8Ab,e, Fig. 8Da,b) .
Expression in the sensory organs
Expression of Group B Sox genes is commonly observed in the primordia of sensory organs derived from sensory placodes. In the epiphysis (pineal body), however, expression of Group B genes is undetectable (Fig. 4B) .
In the nasal epithelium, Sox1, -2, -3 and -21 begin to be expressed concomitantly with development of the nasal placode. Sox2 expression in the presumptive nasal placode begins around stage 9 and becomes distinct at stage 13. Expression of Sox3 and Sox21 is initiated at stage 14, while Sox1 expression starts at stage 15. Expression of these Sox genes continues into later periods in the nasal epithelium (data not shown).
In the developing eyes, Sox1, -2, -3 and -21 are expressed both in the lens and the neural retina (Fig. 8B, for stage 21) . Such expression is not uniform, however, and expression patterns characteristic to individual Sox genes have been Fig. 6 . Comparison of expression of Group B Sox genes in the brain subdivisions and the lens by Northern blotting. Poly (A) 1 RNA were prepared from the head of 6 day embryos, various subdivisions of 13 day embryo brains and lenses of 14 day embryos. Each 1 mg of RNA was electrophoresed and hybridized with speci®c probes not containing the HMG domain sequence. b-actin probe was used to control the RNA loadings. recognized (Fig. 8B) . As reported (Kamachi et al., 1998) , expression of Sox2 and Sox3 was induced in the lens domain of the head ectoderm in response to apposition by the optic vesicle. It was observed that Sox21 expression in the lens Fig. 7 . Expression of Sox2, -14 and -21 in the optic tectum. (A) Optic tectum of stage 29 (6 day) embryos hybridized with the probes indicated. Sox2 is expressed in the ventricular zone (V) and a zone located externally and labeled Ex2. Sox14 is not expressed in the ventricular zone but is expressed in the intermediate zone (I) and more external zones Ex1 and Ex2. Sox21 is expressed in all these zones, with slightly stronger expression in Ex1 than in Ex2. Pial surface is indicated (P). (B) Optic tectum of 12 day embryos. Three layers expressing Group B Sox genes are indicated by the expressed genes, from outside [2/ 14], [14] and [2/14/21]. In the middle panel showing Sox14 expression, the cell layers of the 12 day tectum described by La Veil and Cowan (1971) are indicated by Roman numerals and (ne) (neuroepithelium) for comparison. ectoderm is also initiated at the same stage as Sox2/3 (data not shown). Sox14 is not expressed in the lens (Fig. 8Bd) . Expression of Sox1, -2 and -3 continues to later stages (Fig.  8Ba±c, Fig. 6 ; Kamachi et al., 1998) , while Sox21 expression in the lens (Fig. 8Be) , in contrast, is transient and ceases after 3 days of embryogenesis (Fig. 6 and data not shown).
Inner ear
All Group B Sox genes except for Sox14 are expressed in the primordium of the inner ear. Expression of Sox2, -3 and -21 in the otic placode is initiated at stages 9±10, while Sox1 expression starts slightly before stage 18. Expression of these Sox genes initially covers the whole epithelial surface (ectoderm) of the vesicle, but by the time the embryos reach stage 21 (3 days), Sox expression has become stronger in the medial portion of the vesicle (data not shown). In 6-day embryos where rapid development of the labyrinth takes place (Bissonnette and Fekete, 1996) , expression of Group B Sox genes is con®ned to slightly thickened regions which give rise to the sensory neuroepithelia (Knowlton, 1967) . In the series of sections presented in Fig. 8C , ®ve neuroepithelial patches are shown: the anterior and lateral cristae (ac and lc) located in the ampulae connected to the respective semicircular canals (asc and lsc), the maculae utriculi and sacculi (mu and ms) in the utricle (u) and saccule (s), respectively, and basilar papilla (bp) of the cochlear duct (cd). Innervation of the macula sacculi and the basilar by the neurons of the acoustic ganglion (arrowhead) is clearly visible in Fig. 8Cd .
In all of the sensory epithelia of the inner ear, Sox2 and Sox21 are strongly and rather uniformly expressed, while expression of Sox3 is limited to the cristae (Fig. 8Cc) and Sox1 expression is very weak in the sensory epithelia other than the cristae (Fig. 8Ca) .
Sox3 expression in the primordial germ cells
In the mesentery of the trunk (me), between the mesonephroi, there is a cell population expressing a high level of Sox3 (Fig. 8Dd) . These are large cells, and double staining with periodic acid-Schiff base (PAS) reaction (Meyer, 1960) identi®es them as primordial germ cells (data not shown). Sex of the embryos was not determined, but this Sox3/PAS double positive cell population was observed in all 9 cases examined, arguing that Sox3 expression in the primordial germ cells is sex independent. This expression of Sox3 in the germ cells may be unique to avians, since in the mouse it has been indicated that Sox3 is expressed in the somatic components of the gonad, while Sox2 is expressed in the primordial germ cells (Collignon et al., 1996) .
Sox14 expression in the apical ectodermal ridges and other isolated tissues
Among the class B Sox genes, Sox14 has unique sites of expression. At stage 11, Sox14 is also uniquely expressed in the ventrally located junction of the ectoderm and the amnion, and in a small region of the endoderm (Fig. 3) . It is also expressed in the apical ectodermal ridge of the limb buds, from stage 16 in the forelimb buds and from stage 17 in the hindlimb buds (Fig. 8De , and data not shown).
Discussion
Sox14 and -21 compose a repressing subgroup of Group B Sox genes
In this work, we searched for new members of Group B Sox genes of the chicken, and identi®ed Sox14 and Sox21 and their coding sequences. Sox14 was previously known only by the mouse HMG box sequence, which encodes the same HMG domain as the chicken Sox14 identi®ed in this study. Hargrave et al. (personal communication) have cloned cDNAs with the same coding sequence, and also assigned it to Sox14 of the chicken. Chicken Sox21 sequence in the form of cDNA was independently cloned by Rex et al. (1997b) , although encoded amino acids were different in three positions. Sox14 and Sox21 are highly related genes sharing almost identical HMG domain sequences and being signi®cantly similar in protein organization and in the In situ hybridization for Sox1 (a), Sox2 (b), Sox3 (c) and Sox21 (d) expression in cross sections through the inner ear is shown. As labeled in (a), the sections include anterior semicircular canal (asc), lateral semicircular canal (lsc), lateral ampulla (la), utricle (u), saccule (s), proximal part of the cochlear duct (cd), and the acoustic ganglion (ag) expressing Sox2 located immediately to the left of the inner ear. The junctions between the saccule and the cochlear duct are indicated by bars. In these sections, ®ve of the sensory neuroepithelia, anterior crista (ac), lateral crista (lc), macula utriculi (mu), macula sacculi (ms) and basilar papilla (bp) are shown as labeled in (b). Sox2 and Sox21 are expressed in all these sensory neuroepithelia, while Sox1 expression is low and Sox3 expression is absent in mu, ms and bp. Innervation of the neuroepithelia of mu and adjacent bp from the acoustic ganglion is indicated by arrowheads. conserved amino acid sequences notable throughout the stretch of the proteins. These genes, however, are similar to the classical Group B genes, Sox1, -2 and -3, only in their HMG domain and the Group B homology which continues from the HMG domain (Fig. 1B) . We thus assign Sox1-3 as subgroup B1 and the new genes Sox14 and Sox21 as subgroup B2.
A remarkable ®nding is that the proteins coded by the genes of subgroup B2 act as repressors. In contrast to all previous cases of SOX proteins where transactivation potentials are demonstrated in a C-proximal portion of the protein (SOX1-3 (Kamachi et al., 1995 (Kamachi et al., , 1998 (Kamachi et al., , 1999 ; SOX4 (van de Wetering et al., 1993) ; SOX9 (Su Èdbeck et al., 1996; Ng et al., 1997; Kamachi et al., 1999) ; SOX10 (Pusch et al., 1998); SOX11 (Kuhlbrodt et al., 1998b) ; SOX18 (Hosking et al., 1995) ; SOX24 (Kanda et al., 1998) ), the C-terminal portions of SOX14 and SOX21 act as transrepression domains (Fig. 2C) . It is demonstrated that SOX14/21 repress DC5 d1-crystallin enhancer in a manner dependent on the transrepression domain (Fig. 2D) .
It was previously shown that activation of the DC5 enhancer is the unique property of activator SOX proteins of subgroup B1 (Kamachi et al., 1998 (Kamachi et al., , 1999 . Active repression by SOX14/21 of DC5 enhancer supports the model of their sharing the regulatory target genes with subgroup B1. It has been proposed that target site speci®city of SOX1/2/3 is conferred by their speci®c interaction with partner factors which are uniquely shared by Group B SOX proteins (Kamachi et al., 1999) . This interaction presumably stabilizes the DNA binding of the SOX proteins, and effectuates the transcriptional regulation associated with the C-proximal portion of the protein. The major site of SOX2 protein interacting with the partner factors is mapped at the immediate C-proximal side of the HMG domain (Kamachi et al., 1999) . It is possible that Group B homology (Fig. 1) , common to both activating and repressing Group B SOX, is one of the partner interaction sites of Group B SOX proteins.
Signi®cance of combinatorial expression of Group B Sox genes
There are many tissues expressing multiple Group B Sox genes at once. If their regulatory target sequences carry only a single SOX binding site, then combinatorial expression of cognate SOX proteins would lead to competition among them. However, in most of the natural target genes of SOX proteins, plural SOX binding sites have been identi®ed. In d1-crystallin enhancer, for instance, there is only a single SOX binding site in the sequence of the minimal enhancer DC5 (Kamachi et al., 1995) , but in the natural full-length enhancer, we have identi®ed a second SOX binding site outside DC5 which greatly affects the enhancer strength (Muta, M., Kamachi, Y., Higashi, Y. and Kondoh, H., unpublished data) . Perhaps the genes regulated by Group B proteins will have regulatory sites bound by multiple SOX proteins expressed in the same cells, and the expression level of the genes will be determined by the overall effect of the bound proteins.
Most of the combinatorial expressions of these genes can be grouped within the following three patterns: (1) Expression of Sox1 or Sox3 occurs in a subset of Sox2-expressing tissues, sometimes nearly overlapping with Sox2; (2) Expression of Sox21 often overlaps with Sox2 expression; (3) In certain domains of the CNS, Sox21 expression is followed by Sox14 expression.
A striking observation is that expression of Sox2 and Sox21 overlaps so extensively in various tissues, which corresponds to the second pattern of combinatorial expression. The¯oor plate of the spinal cord (Fig. 4A ), early lenses (Fig. 8B) , and rostral part of the alimentary tract (Fig. 8A,D) are some of the examples. As SOX2 and SOX21 have opposite activities as transcriptional regulators, it may be that proper development of such tissues that express Sox2 and Sox21 together is achieved on a balance of activation and repression of the target genes rather than their full activation. Alternatively, combination of SOX2 and SOX21 may produce a new activity for gene regulation in certain contexts of cells and target genes.
A typical example showing the combinatorial expression patterns of the ®rst and second categories is the development of the inner ear (Fig. 8C) . At stages of day 6 when the basic architecture of the inner ear is established (Bissonnette and Fekete, 1996; Knowlton, 1967) , Sox2 and Sox21 are expressed in all the sites of the primordia of the sensory epithelium, but strong expression of Sox1 and Sox3 is con®ned to the cristae, implying that the latter two Sox genes differentiate the cristae from other sensory epithelia.
Expression of Sox genes in the nervous system
The major site of expression of Group B Sox genes is the CNS. In fact, Sox genes of subgroup B1 have been strongly implicated in neurogenesis. Sox2 is most widely expressed in the CNS (Uwanogho et al., 1995) and re¯ects the neural state of the early embryonic ectoderm (Streit et al., 1997) . Its overexpression in the Xenopus egg together with FGF expands the neural area of the embryo ectoderm (Mizuseki et al., 1998) . Overexpression of Sox1 provides P19 teratocarcinoma cells with the neural fate of differentiation (Pevny et al., 1998) . Thus, Sox genes of subgroup B1 seem to bestow the neural properties of the early CNS tissues. Combinatorial expression of activating (subgroup B1) and repressing (subgroup B2) Sox genes very often coexist throughout the CNS. The simplest case is the ventricular zone of the spinal cord where Sox1, -2, -3 and -21 are expressed. It has been demonstrated in the spinal cord of mouse embryos that Sox1 expression occurs only in the population undergoing cell division, and Sox1 expression is extinct in post-mitotic cells, e.g., those of the¯oor plate (Pevny et al., 1998) . Sox3, showing a similar expression pattern (Rex et al., 1997a; Kamachi et al., 1998) , may also be under analogous regulation. On the other hand, expression of Sox2 and Sox21 extends to the¯oor plate (Fig. 4A) , which may imply a speci®c function of the coexpressed genes in this particular post-mitotic tissue.
In the rhombencephalon, expression and the pattern of overlap of Group B Sox genes change dynamically with development ( Table 1 ). The units of expression domains of the genes are initially in accordance with the rhombomere boundaries, but later dorso-ventral subdivisions occur which seem to be correlated with the dorso-ventral striations of Sox21 expression in early stages ( Fig. 4A ; Rex et al., 1997b) . Thus, checkerboard-like compartments of rhombencephalon result.
As the brain develops, expression of Group B Sox genes seems to create newer subdivisions in a pre-existing domain by local increase or decrease of the expression levels (Figs. 3 and 5, and data not shown). The domains and their subdivisions of the brain discernible by the combination of the Sox expression are in good agreement with those proposed for diencephalon by Figdor and Stern (1993) . The Sox expression, probably in cooperation with other domainspeci®c transcription factors, appears to specify various subdivisions of the brain, as is indicated for mouse embryos based on expression of other genes (Bulfone et al., 1993) .
Expression domains of Group B Sox genes also raise the problem of speci®city and functional redundancy among the related genes. In the brain of 5 day embryos, the domains which express Sox1 and Sox3 are entirely covered by those of Sox2, but expression of Sox1 and Sox3 is accentuated at sites unique to each Sox. One would speculate that in these domains, besides the total activation potential of subgroup B1 Sox genes being highly augmented, Sox1 or Sox3 is exerting its speci®c effects. Sox1 knockout mice display only minor phenotypes in the brain (Nishiguchi et al., 1998) , probably re¯ecting extensive functional overlap among subgroup B1 genes, but it is of great interest to correlate the sites affected in the mutants and the site of Sox1 expression in certain stages of brain development, which may indicate a function unique to Sox1.
In a few speci®c domains of the CNS, Sox14 and Sox21 of subgroup B2 are coexpressed when cells are to undergo terminal differentiation after emigrating out of the ventricular zone (Figs. 4 and 7) . The interneuron precursors in the spinal cord (Fig. 4A) are a good example. In these domains of the CNS, Sox21 expression starting in the ventricular zone continues in the intermediate zone, but is gradually taken over by expression of Sox14. The transition from strong repressor Sox21 to modest repressor Sox14 may cause a shift of expression levels of the same target genes, and this shift may underlie the maturation process of the CNS cells expressing subgroup B2 Sox genes. An analogous situation seems to exist in the cells on the ventral border of the internal cellular area of the dorsal thalamus in which Sox21 expression is stronger in the cells closer to the ventricular zone, while Sox14 expression is stronger in those farther away (Fig. 4B ). An interesting observation there is that a Sox2-expressing cell population overlies that expressing Sox14/21, presumably resulting in two adjacent cell populations with highly distinct characters owing to the opposite activities of Sox2 and Sox14/21.
A more elaborate case is the optic tectum where Group B Sox genes seem to contribute to speci®cation of cell layers (Fig. 7) . Besides the common feature of the subgroup B gene expression, stronger Sox21 expression in the ventricular side and stronger Sox14 expression in the opposite side, a new pattern of complexity arises in that expression of Sox2 occurs in sublayers of Sox14-expressing layers. In an immediately neighboring cell layer Sox14 and Sox21 are expressed together which presumably builds up a highly repressing activity of Group B Sox genes. It is conceivable that differential levels of expression of the target genes shared by subgroup B1 and subgroup B2 initiate differentiation of tectum cell layers.
It is interesting that Sox2 and Sox3 appear to be expressed in subsets of neural crest-derived tissues (Fig. 8C,D) . Sox2 is expressed in all neural derivatives of the neural crest cells, including adrenomedulla, as well as analogous neural tissues derived from the cephalic placodes. Sox3, on the other hand, is expressed only in the autonomic nervous system. This is in contrast to the case of Sox10, which is expressed very widely among neural crest-originated tissues (Tani et al., 1997; Kuhlbrodt et al., 1998a; Southard-Smith et al., 1998) . It is possible that Sox10 expression de®nes the neural crest cells, and in this population Sox2 and Sox3 de®ne the neural fate.
Cases of unique expression patterns
As discussed above, Group B Sox genes are expressed in most cases in combination with other group member genes. However, there are also cases in which a single Sox gene is uniquely expressed. We brie¯y discuss two such cases, Sox3 expression in the primordial germ cells and Sox14 expression in the apical ectodermal ridges (AER) of the limb buds.
Sox3 is expressed in the population of large cells distributed primarily in the mesentery at stage 21 (Fig. 8Dd) . Most of these Sox3-positive cells are stained strongly by PAS, identifying them as primordial germ cells (Meyer, 1960) . In Xenopus laevis also, it is reported that Sox3 is expressed in the oocyte (Koyano et al., 1997) . In the mouse, Sox1, -2 and -3 are all expressed in the genital ridges, and Sox3 expression is higher in the female gonad. In the mouse, however, Sox3 is expressed in the somatic cells rather than the primordial germ cells, and Sox2 is instead expressed in the germ cells (Collignon et al., 1996) . It is intriguing to note that, in the chicken, Sox3 is also expressed in the epiblast (Rex et al., 1997a) , while Sox2 is instead expressed in the epiblast of the mouse (unpublished result of Nicolis et al. cited in Pevny et al., 1998) . It is also known that the cells of epiblast-germ cell lineage express Oct3/4, and cooperation of SOX2 and OCT3/4 has been reported to regulate the FGF4 enhancer (Yuan et al., 1995; Ambrosetti et al., 1997) . It is possible that Sox2 function in the Oct3/4-expressing lineage in the mouse embryo is replaced by that of Sox3 in the chicken.
In the limb buds, Sox14 is uniquely expressed in the AER (Fig. 8De) . Sox14 is one of the few transcription factor genes known to be expressed exclusively in the AER compartment of a limb bud. It is speculated that the genetic mechanism which de®nes the dorso-ventral border of the limb activates Sox14. Given that SOX14 is a repressor, its expression may inhibit a set of genes to be expressed in surface ectoderm and may differentiate the AER.
Experimental procedures
Isolation of Sox genes
Chicken genomic libraries were produced by ligation of Sau3AI partial digest of genomic DNA with the arms of lEMBL3 or lFIXII vectors. The plaques were screened by hybridization with a 32 P-labeled Sox2 fragment probe including the HMG box sequence (positions 69±1013; Kamachi et al., 1995) in 6£ SSPE, 0.05% BLOTTO, 0.25% NP-40 at 658C overnight followed by repeated washes in 2£ SSC, 0.1% SDS at 608C. This screening identi®ed Sox1, -2, -3, -14 and -21 clones. The inserts of Sox14 and Sox21 clones were roughly mapped for restriction sites, and a SmaI-BglII fragment (2315 bps) of Sox14 and a BamHI-SmaI fragment (2217 bps) of Sox21 were subcloned into pBluescript II SK1 (Stratagene) and fully sequenced using a dideoxy method.
Probes for insutu hybridization
Digoxigenin-labelled riboprobes of Sox genes were produced by in vitro transcription of subcloned gene-speci®c fragments with T7 or T3 RNA polymerase. Sox1-3 probes were made as described (Kamachi et al., 1998) . Sox14 probe, a 587 bp BspMI-SacII (position 1041±1627) and Sox21 probe, a 718 bp HgiAI-HgiAI (position 1208± 1925 . Both antisense and sense probes were used, and sense probes gave no signal above the background.
Whole mount in situ hybridization
This was done according to Wilkinson (1992) with the following modi®cations. Hybridization medium contained 1% CHAPS instead of SDS. Incubation with glycine solution after Proteinase K treatment was omitted. Anti-digoxigenin antibody was reacted in 1.5% Blocking Reagent (Boehringer Mannheim) rather than in goat serum.
In situ hybridization of histological sections
The procedure was essentially the same as Rex et al. (1997b) , except that antibody reactions were done in 150 mM NaCl, 100 mM Tris±HCl (pH 7.5).
Periodic acid-Schiff base (PAS) reaction
Tissue sections on glass slides prepared for in situ hybridization were processed according to Meyer et al. (1960) .
Northern blotting
Poly(A)1 RNA was isolated from total RNA using PolyATtract TM mRNA Isolation System IV (Promega) derived from embryonic tissues. One microgram of poly(A)1 RNA was electrophoresed per lane. The 32 Plabeled probes of the same Sox sequences as used for in situ hybridization were synthesized using the Strip-EZ system (Ambion). Hybridization was done according to Kamachi et al. (1998) .
Gel mobility shift assay
S-Tag-SOX fusion proteins were synthesized in a transcription/translation coupled reticulocyte lysate system (TNT, Promega) using as template the plasmid pCITE-3 containing Sox cDNAs. Synthesized S-Tag fusion proteins were estimated by S-Tag rapid assay (Novagen) and 0.7±0.9 ml of the lysate containing 2 ng fusion proteins was used in gel mobility shift assays carried out under the conditions described in Kamachi and Kondoh (1993) . The probe DC12 was a subfragment of DC5 containing the SOX binding site (Kamachi and Kondoh, 1993) .
Transfection
To express exogenous SOX proteins in cultured cells, Sox14 and Sox21 cDNAs were inserted into cytomegalovirus (CMV)-driven expression vector pCMV/SV2 as previously described for Sox1 and Sox2 cDNAs (Kamachi et al., 1999) . The SOX21 C-terminal deletion mutant (SOX21DC) was made by digestion with ApaI, which leaves N-terminal 125 amino acids. The luciferase reporter vector with octameric DC5 sequence has been described (Kamachi and Kondoh, 1993) . Lens cells from 14 day chicken embryos were cultured in a 35 mm diameter dish (Kamachi et al., 1999) and transfected with plasmid DNA containing 1.3 mg of luciferase reporter, 0.1 mg of a mixture of Sox expression vector plus insert-free vector, and 0.1 mg of pSVb-Galactosidase (Promega) using a calcium phosphate precipitation method (Chen and Okayama, 1987) . Luciferase activity was measured 48 h after transfection and normalized with b -galactosidase activity as described by Kamachi et al. (1998) . To construct the effector expression vectors for GAL4 fusions, cDNA fragments encoding Cterminal domains of SOX14 (aa 85±240) and SOX21 (aa 85±280) were ampli®ed by PCR and inserted into the pCMV/SV2-GAL4DBD (Kamachi et al., 1999) . The luciferase reporter vector with the four copies of Gal4 binding sequence has been described (Sekido et al., 1997) . All transfections were carried out at least three times.
